Global Pharmaceutical CDMO Market Size study & Forecast, by Product (API, Drug) by Workflow (Clinical, Commercial) by Application (Oncology, Hormonal, Glaucoma, Cardiovascular Disease, Diabetes, Others) and Regional Analysis, 2023-2030
Global Pharmaceutical CDMO Market is valued approximately at USD 136.94 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 6.1% over the forecast period 2023-2030. Pharmaceutical CDMO (Contract Development and Manufacturing Organization) is a type of company that provides outsourced services for the pharmaceutical industry, including drug development, manufacturing, and packaging. CDMOs work on behalf of pharmaceutical companies that do not have the internal resources, expertise, or facilities to undertake certain aspects of drug development or manufacturing.
Numerous causes, such as the rising demand for biopharmaceuticals, improvements in manufacturing technology, and the tendency to outsource medication development and manufacture, are responsible for the expansion. The pharmaceutical industry's contract development and manufacturing organization (CDMO) market is a crucial one, and its expansion is anticipated to benefit the entire healthcare sector.
The pharmaceutical CDMO market is expected to grow in the future years as a result of the industry's significant R&D expenditures and the expanding need for biopharmaceuticals. The market for medicines is likely to expand as the ageing population creates new opportunities for drug development. Since they provide pharmaceutical businesses with cost-effective solutions and a shorter time to market through the outsourcing of drug development and production, CDMOs are an essential component of the pharmaceutical industry. In addition, the rise of the biopharma industry, with China emerging as a prominent player, is anticipated to accelerate. Pharmaceutical businesses continually invest in R&D, which is fueling improvements in biopharmaceuticals and the development of fresh therapies and cures. It is anticipated that this pattern would continue, with the top 15 businesses spending a record amount on R&D in 2020. Global pharmaceutical R&D investment is anticipated to increase due to the rising prevalence of chronic diseases and the creation of biosimilars, thus boosting the market's expansion. In general, the pharmaceutical CDMO future is bright, with several expansion potential opening in the pharmaceutical sector. Additionally, the market is expanding due to the rising incidence of cancer worldwide, which will account for 10 million deaths worldwide in 2021 and be the leading cause of death. It is anticipated that there would be an increase in the demand for innovative cancer therapies, creating opportunities for pharmaceutical and CDMO businesses. In 2020, it is anticipated that the pipeline for oncology medicines in the pharmaceutical sector would make up about 30% of it. With more than 12.5 million new instances of cancer diagnosed each year, the oncology sector is still difficult, time-consuming, and evolving despite the advances in detection and treatment. However, the high cost of Pharmaceutical CDMO stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Pharmaceutical CDMO Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. The market is divided into different geographic segments, with Asia Pacific expected to have the quickest CAGR growth throughout the projected period and have the greatest market share in 2022. The APAC region's market expansion can be attributable to lower manufacturing costs than those in North America and Europe, which makes it a desirable outsourcing hub for the creation of pharmaceuticals. The region's market is expanding due to the presence of university-affiliated pharmaceutical research hubs and significant funding. Due to favorable legislation and much lower production costs in North America and Europe, India and China are leading the market for contract development and manufacturing organizations.
Major market player included in this report are:
Bushu Pharmaceuticals Ltd.
Nipro Corporation
Thermo Fisher Scientific Inc.
Samsung Biologics
Laboratory Corporation of America Holdings
Siegfried Holding Ag
Catalent, Inc
Lonza Group AG
Recipharm Ab
Piramal Pharma Solutions
Recent Developments in the Market:
In 2020, WuXi AppTec, a Chinese-based Pharmaceutical CDMO, announced the launch of a new digital technology platform to enable end-to-end supply chain management for the pharmaceutical industry.
Some Pharmaceutical CDMOs are adopting sustainability initiatives to reduce their environmental impact. In 2021, Lonza announced its commitment to achieve net-zero greenhouse gas emissions by 2050 and to reduce its carbon footprint by 50% by 2030.
Global Pharmaceutical CDMO Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Product, Workflow, Application, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
API
Drug
By Workflow:
Clinical
Commercial
By Application:
Oncology
Hormonal
Glaucoma
Cardiovascular Disease
Diabetes
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
Numerous causes, such as the rising demand for biopharmaceuticals, improvements in manufacturing technology, and the tendency to outsource medication development and manufacture, are responsible for the expansion. The pharmaceutical industry's contract development and manufacturing organization (CDMO) market is a crucial one, and its expansion is anticipated to benefit the entire healthcare sector.
The pharmaceutical CDMO market is expected to grow in the future years as a result of the industry's significant R&D expenditures and the expanding need for biopharmaceuticals. The market for medicines is likely to expand as the ageing population creates new opportunities for drug development. Since they provide pharmaceutical businesses with cost-effective solutions and a shorter time to market through the outsourcing of drug development and production, CDMOs are an essential component of the pharmaceutical industry. In addition, the rise of the biopharma industry, with China emerging as a prominent player, is anticipated to accelerate. Pharmaceutical businesses continually invest in R&D, which is fueling improvements in biopharmaceuticals and the development of fresh therapies and cures. It is anticipated that this pattern would continue, with the top 15 businesses spending a record amount on R&D in 2020. Global pharmaceutical R&D investment is anticipated to increase due to the rising prevalence of chronic diseases and the creation of biosimilars, thus boosting the market's expansion. In general, the pharmaceutical CDMO future is bright, with several expansion potential opening in the pharmaceutical sector. Additionally, the market is expanding due to the rising incidence of cancer worldwide, which will account for 10 million deaths worldwide in 2021 and be the leading cause of death. It is anticipated that there would be an increase in the demand for innovative cancer therapies, creating opportunities for pharmaceutical and CDMO businesses. In 2020, it is anticipated that the pipeline for oncology medicines in the pharmaceutical sector would make up about 30% of it. With more than 12.5 million new instances of cancer diagnosed each year, the oncology sector is still difficult, time-consuming, and evolving despite the advances in detection and treatment. However, the high cost of Pharmaceutical CDMO stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Pharmaceutical CDMO Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. The market is divided into different geographic segments, with Asia Pacific expected to have the quickest CAGR growth throughout the projected period and have the greatest market share in 2022. The APAC region's market expansion can be attributable to lower manufacturing costs than those in North America and Europe, which makes it a desirable outsourcing hub for the creation of pharmaceuticals. The region's market is expanding due to the presence of university-affiliated pharmaceutical research hubs and significant funding. Due to favorable legislation and much lower production costs in North America and Europe, India and China are leading the market for contract development and manufacturing organizations.
Major market player included in this report are:
Bushu Pharmaceuticals Ltd.
Nipro Corporation
Thermo Fisher Scientific Inc.
Samsung Biologics
Laboratory Corporation of America Holdings
Siegfried Holding Ag
Catalent, Inc
Lonza Group AG
Recipharm Ab
Piramal Pharma Solutions
Recent Developments in the Market:
In 2020, WuXi AppTec, a Chinese-based Pharmaceutical CDMO, announced the launch of a new digital technology platform to enable end-to-end supply chain management for the pharmaceutical industry.
Some Pharmaceutical CDMOs are adopting sustainability initiatives to reduce their environmental impact. In 2021, Lonza announced its commitment to achieve net-zero greenhouse gas emissions by 2050 and to reduce its carbon footprint by 50% by 2030.
Global Pharmaceutical CDMO Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Product, Workflow, Application, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
API
Drug
By Workflow:
Clinical
Commercial
By Application:
Oncology
Hormonal
Glaucoma
Cardiovascular Disease
Diabetes
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Pharmaceutical CDMO Market, by Region, 2020-2030 (USD Billion)
1.2.2. Pharmaceutical CDMO Market, by Product, 2020-2030 (USD Billion)
1.2.3. Pharmaceutical CDMO Market, by Workflow, 2020-2030 (USD Billion)
1.2.4. Pharmaceutical CDMO Market, by Application, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL PHARMACEUTICAL CDMO MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL PHARMACEUTICAL CDMO MARKET DYNAMICS
3.1. Pharmaceutical CDMO Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing demand for biopharmaceuticals
3.1.1.2. Increasing Cases of Cancer across the Globe
3.1.2. Market Challenges
3.1.2.1. High Cost of Pharmaceutical CDMO
3.1.3. Market Opportunities
3.1.3.1. Technological advancements in manufacturing
CHAPTER 4. GLOBAL PHARMACEUTICAL CDMO MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL PHARMACEUTICAL CDMO MARKET, BY PRODUCT
5.1. Market Snapshot
5.2. Global Pharmaceutical CDMO Market by Product, Performance - Potential Analysis
5.3. Global Pharmaceutical CDMO Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
5.4. Pharmaceutical CDMO Market, Sub Segment Analysis
5.4.1. API
5.4.2. Drug
CHAPTER 6. GLOBAL PHARMACEUTICAL CDMO MARKET, BY WORKFLOW
6.1. Market Snapshot
6.2. Global Pharmaceutical CDMO Market by Workflow, Performance - Potential Analysis
6.3. Global Pharmaceutical CDMO Market Estimates & Forecasts by Workflow 2020-2030 (USD Billion)
6.4. Pharmaceutical CDMO Market, Sub Segment Analysis
6.4.1. Clinical
6.4.2. Commercial
CHAPTER 7. GLOBAL PHARMACEUTICAL CDMO MARKET, BY APPLICATION
7.1. Market Snapshot
7.2. Global Pharmaceutical CDMO Market by Application, Performance - Potential Analysis
7.3. Global Pharmaceutical CDMO Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
7.4. Pharmaceutical CDMO Market, Sub Segment Analysis
7.4.1. Oncology
7.4.2. Hormonal
7.4.3. Glaucoma
7.4.4. Cardiovascular Disease
7.4.5. Diabetes
7.4.6. Others
CHAPTER 8. GLOBAL PHARMACEUTICAL CDMO MARKET, REGIONAL ANALYSIS
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Pharmaceutical CDMO Market, Regional Market Snapshot
8.4. North America Pharmaceutical CDMO Market
8.4.1. U.S. Pharmaceutical CDMO Market
8.4.1.1. Product breakdown estimates & forecasts, 2020-2030
8.4.1.2. Workflow breakdown estimates & forecasts, 2020-2030
8.4.1.3. Application breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Pharmaceutical CDMO Market
8.5. Europe Pharmaceutical CDMO Market Snapshot
8.5.1. U.K. Pharmaceutical CDMO Market
8.5.2. Germany Pharmaceutical CDMO Market
8.5.3. France Pharmaceutical CDMO Market
8.5.4. Spain Pharmaceutical CDMO Market
8.5.5. Italy Pharmaceutical CDMO Market
8.5.6. Rest of Europe Pharmaceutical CDMO Market
8.6. Asia-Pacific Pharmaceutical CDMO Market Snapshot
8.6.1. China Pharmaceutical CDMO Market
8.6.2. India Pharmaceutical CDMO Market
8.6.3. Japan Pharmaceutical CDMO Market
8.6.4. Australia Pharmaceutical CDMO Market
8.6.5. South Korea Pharmaceutical CDMO Market
8.6.6. Rest of Asia Pacific Pharmaceutical CDMO Market
8.7. Latin America Pharmaceutical CDMO Market Snapshot
8.7.1. Brazil Pharmaceutical CDMO Market
8.7.2. Mexico Pharmaceutical CDMO Market
8.8. Middle East & Africa Pharmaceutical CDMO Market
8.8.1. Saudi Arabia Pharmaceutical CDMO Market
8.8.2. South Africa Pharmaceutical CDMO Market
8.8.3. Rest of Middle East & Africa Pharmaceutical CDMO Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Key Company SWOT Analysis
9.1.1. Company
9.1.2. Company
9.1.3. Company
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Bushu Pharmaceuticals Ltd.
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Nipro Corporation
9.3.3. Thermo Fisher Scientific Inc.
9.3.4. Samsung Biologics
9.3.5. Laboratory Corporation of America Holdings
9.3.6. Siegfried Holding Ag
9.3.7. Catalent, Inc
9.3.8. Lonza Group AG
9.3.9. Recipharm Ab
9.3.10. Piramal Pharma Solutions
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Pharmaceutical CDMO Market, by Region, 2020-2030 (USD Billion)
1.2.2. Pharmaceutical CDMO Market, by Product, 2020-2030 (USD Billion)
1.2.3. Pharmaceutical CDMO Market, by Workflow, 2020-2030 (USD Billion)
1.2.4. Pharmaceutical CDMO Market, by Application, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL PHARMACEUTICAL CDMO MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL PHARMACEUTICAL CDMO MARKET DYNAMICS
3.1. Pharmaceutical CDMO Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing demand for biopharmaceuticals
3.1.1.2. Increasing Cases of Cancer across the Globe
3.1.2. Market Challenges
3.1.2.1. High Cost of Pharmaceutical CDMO
3.1.3. Market Opportunities
3.1.3.1. Technological advancements in manufacturing
CHAPTER 4. GLOBAL PHARMACEUTICAL CDMO MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL PHARMACEUTICAL CDMO MARKET, BY PRODUCT
5.1. Market Snapshot
5.2. Global Pharmaceutical CDMO Market by Product, Performance - Potential Analysis
5.3. Global Pharmaceutical CDMO Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
5.4. Pharmaceutical CDMO Market, Sub Segment Analysis
5.4.1. API
5.4.2. Drug
CHAPTER 6. GLOBAL PHARMACEUTICAL CDMO MARKET, BY WORKFLOW
6.1. Market Snapshot
6.2. Global Pharmaceutical CDMO Market by Workflow, Performance - Potential Analysis
6.3. Global Pharmaceutical CDMO Market Estimates & Forecasts by Workflow 2020-2030 (USD Billion)
6.4. Pharmaceutical CDMO Market, Sub Segment Analysis
6.4.1. Clinical
6.4.2. Commercial
CHAPTER 7. GLOBAL PHARMACEUTICAL CDMO MARKET, BY APPLICATION
7.1. Market Snapshot
7.2. Global Pharmaceutical CDMO Market by Application, Performance - Potential Analysis
7.3. Global Pharmaceutical CDMO Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
7.4. Pharmaceutical CDMO Market, Sub Segment Analysis
7.4.1. Oncology
7.4.2. Hormonal
7.4.3. Glaucoma
7.4.4. Cardiovascular Disease
7.4.5. Diabetes
7.4.6. Others
CHAPTER 8. GLOBAL PHARMACEUTICAL CDMO MARKET, REGIONAL ANALYSIS
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Pharmaceutical CDMO Market, Regional Market Snapshot
8.4. North America Pharmaceutical CDMO Market
8.4.1. U.S. Pharmaceutical CDMO Market
8.4.1.1. Product breakdown estimates & forecasts, 2020-2030
8.4.1.2. Workflow breakdown estimates & forecasts, 2020-2030
8.4.1.3. Application breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Pharmaceutical CDMO Market
8.5. Europe Pharmaceutical CDMO Market Snapshot
8.5.1. U.K. Pharmaceutical CDMO Market
8.5.2. Germany Pharmaceutical CDMO Market
8.5.3. France Pharmaceutical CDMO Market
8.5.4. Spain Pharmaceutical CDMO Market
8.5.5. Italy Pharmaceutical CDMO Market
8.5.6. Rest of Europe Pharmaceutical CDMO Market
8.6. Asia-Pacific Pharmaceutical CDMO Market Snapshot
8.6.1. China Pharmaceutical CDMO Market
8.6.2. India Pharmaceutical CDMO Market
8.6.3. Japan Pharmaceutical CDMO Market
8.6.4. Australia Pharmaceutical CDMO Market
8.6.5. South Korea Pharmaceutical CDMO Market
8.6.6. Rest of Asia Pacific Pharmaceutical CDMO Market
8.7. Latin America Pharmaceutical CDMO Market Snapshot
8.7.1. Brazil Pharmaceutical CDMO Market
8.7.2. Mexico Pharmaceutical CDMO Market
8.8. Middle East & Africa Pharmaceutical CDMO Market
8.8.1. Saudi Arabia Pharmaceutical CDMO Market
8.8.2. South Africa Pharmaceutical CDMO Market
8.8.3. Rest of Middle East & Africa Pharmaceutical CDMO Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Key Company SWOT Analysis
9.1.1. Company
9.1.2. Company
9.1.3. Company
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Bushu Pharmaceuticals Ltd.
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Nipro Corporation
9.3.3. Thermo Fisher Scientific Inc.
9.3.4. Samsung Biologics
9.3.5. Laboratory Corporation of America Holdings
9.3.6. Siegfried Holding Ag
9.3.7. Catalent, Inc
9.3.8. Lonza Group AG
9.3.9. Recipharm Ab
9.3.10. Piramal Pharma Solutions
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Pharmaceutical CDMO Market, report scope
TABLE 2. Global Pharmaceutical CDMO Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Pharmaceutical CDMO Market estimates & forecasts by Product 2020-2030 (USD Billion)
TABLE 4. Global Pharmaceutical CDMO Market estimates & forecasts by Workflow 2020-2030 (USD Billion)
TABLE 5. Global Pharmaceutical CDMO Market estimates & forecasts by Application 2020-2030 (USD Billion)
TABLE 6. Global Pharmaceutical CDMO Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Pharmaceutical CDMO Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Pharmaceutical CDMO Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Pharmaceutical CDMO Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Pharmaceutical CDMO Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Pharmaceutical CDMO Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Pharmaceutical CDMO Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Pharmaceutical CDMO Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Pharmaceutical CDMO Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Pharmaceutical CDMO Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Pharmaceutical CDMO Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. U.S. Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. Canada Pharmaceutical CDMO Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 20. Canada Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. Canada Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. UK Pharmaceutical CDMO Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 23. UK Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. UK Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. Germany Pharmaceutical CDMO Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 26. Germany Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. Germany Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. France Pharmaceutical CDMO Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 29. France Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. France Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. Italy Pharmaceutical CDMO Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 32. Italy Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Italy Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Spain Pharmaceutical CDMO Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 35. Spain Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. Spain Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. RoE Pharmaceutical CDMO Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 38. RoE Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. RoE Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. China Pharmaceutical CDMO Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 41. China Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. China Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. India Pharmaceutical CDMO Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 44. India Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. India Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. Japan Pharmaceutical CDMO Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 47. Japan Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. Japan Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. South Korea Pharmaceutical CDMO Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 50. South Korea Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. South Korea Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. Australia Pharmaceutical CDMO Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 53. Australia Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. Australia Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. RoAPAC Pharmaceutical CDMO Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 56. RoAPAC Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. RoAPAC Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. Brazil Pharmaceutical CDMO Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 59. Brazil Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Brazil Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Mexico Pharmaceutical CDMO Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 62. Mexico Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. Mexico Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. RoLA Pharmaceutical CDMO Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 65. RoLA Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. RoLA Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. Saudi Arabia Pharmaceutical CDMO Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 68. South Africa Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. RoMEA Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Pharmaceutical CDMO Market
TABLE 71. List of primary sources, used in the study of global Pharmaceutical CDMO Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Pharmaceutical CDMO Market, report scope
TABLE 2. Global Pharmaceutical CDMO Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Pharmaceutical CDMO Market estimates & forecasts by Product 2020-2030 (USD Billion)
TABLE 4. Global Pharmaceutical CDMO Market estimates & forecasts by Workflow 2020-2030 (USD Billion)
TABLE 5. Global Pharmaceutical CDMO Market estimates & forecasts by Application 2020-2030 (USD Billion)
TABLE 6. Global Pharmaceutical CDMO Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Pharmaceutical CDMO Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Pharmaceutical CDMO Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Pharmaceutical CDMO Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Pharmaceutical CDMO Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Pharmaceutical CDMO Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Pharmaceutical CDMO Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Pharmaceutical CDMO Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Pharmaceutical CDMO Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Pharmaceutical CDMO Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Pharmaceutical CDMO Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. U.S. Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. Canada Pharmaceutical CDMO Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 20. Canada Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. Canada Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. UK Pharmaceutical CDMO Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 23. UK Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. UK Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. Germany Pharmaceutical CDMO Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 26. Germany Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. Germany Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. France Pharmaceutical CDMO Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 29. France Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. France Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. Italy Pharmaceutical CDMO Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 32. Italy Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Italy Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Spain Pharmaceutical CDMO Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 35. Spain Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. Spain Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. RoE Pharmaceutical CDMO Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 38. RoE Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. RoE Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. China Pharmaceutical CDMO Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 41. China Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. China Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. India Pharmaceutical CDMO Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 44. India Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. India Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. Japan Pharmaceutical CDMO Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 47. Japan Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. Japan Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. South Korea Pharmaceutical CDMO Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 50. South Korea Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. South Korea Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. Australia Pharmaceutical CDMO Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 53. Australia Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. Australia Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. RoAPAC Pharmaceutical CDMO Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 56. RoAPAC Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. RoAPAC Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. Brazil Pharmaceutical CDMO Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 59. Brazil Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Brazil Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Mexico Pharmaceutical CDMO Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 62. Mexico Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. Mexico Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. RoLA Pharmaceutical CDMO Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 65. RoLA Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. RoLA Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. Saudi Arabia Pharmaceutical CDMO Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 68. South Africa Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. RoMEA Pharmaceutical CDMO Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Pharmaceutical CDMO Market
TABLE 71. List of primary sources, used in the study of global Pharmaceutical CDMO Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Pharmaceutical CDMO Market, research methodology
FIG 2. Global Pharmaceutical CDMO Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Pharmaceutical CDMO Market, key trends 2022
FIG 5. Global Pharmaceutical CDMO Market, growth prospects 2023-2030
FIG 6. Global Pharmaceutical CDMO Market, porters 5 force model
FIG 7. Global Pharmaceutical CDMO Market, pest analysis
FIG 8. Global Pharmaceutical CDMO Market, value chain analysis
FIG 9. Global Pharmaceutical CDMO Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Pharmaceutical CDMO Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Pharmaceutical CDMO Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Pharmaceutical CDMO Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Pharmaceutical CDMO Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Pharmaceutical CDMO Market, regional snapshot 2020 & 2030
FIG 15. North America Pharmaceutical CDMO Market 2020 & 2030 (USD Billion)
FIG 16. Europe Pharmaceutical CDMO Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Pharmaceutical CDMO Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Pharmaceutical CDMO Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Pharmaceutical CDMO Market 2020 & 2030 (USD Billion)
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Pharmaceutical CDMO Market, research methodology
FIG 2. Global Pharmaceutical CDMO Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Pharmaceutical CDMO Market, key trends 2022
FIG 5. Global Pharmaceutical CDMO Market, growth prospects 2023-2030
FIG 6. Global Pharmaceutical CDMO Market, porters 5 force model
FIG 7. Global Pharmaceutical CDMO Market, pest analysis
FIG 8. Global Pharmaceutical CDMO Market, value chain analysis
FIG 9. Global Pharmaceutical CDMO Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Pharmaceutical CDMO Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Pharmaceutical CDMO Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Pharmaceutical CDMO Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Pharmaceutical CDMO Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Pharmaceutical CDMO Market, regional snapshot 2020 & 2030
FIG 15. North America Pharmaceutical CDMO Market 2020 & 2030 (USD Billion)
FIG 16. Europe Pharmaceutical CDMO Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Pharmaceutical CDMO Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Pharmaceutical CDMO Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Pharmaceutical CDMO Market 2020 & 2030 (USD Billion)
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
